Nirjhar Chatterjee

2 years ago By Ben Parkes

Topic: How RWE can allow for more informed and reliable strategic decisions earlier when it comes to patient safety Nirjhar Chatterjee, MD has more than 26 years’ experience in the pharmaceutical and biological industry in Safety, Medical Affairs, Clinical Research and Clinical Development in various therapeutic fields, such as: Haematology, Gastroenterology, Hepatology, Digestive Surgery, Rheumatology, Infectious diseases, Neonatology, Immunology & Vaccines. He is currently the Global Safety Lead (GSL) – Medical Director in Global Patient Safety Evaluation (GPSE) at Takeda, based in Cambridge, MA. Previously, he has worked in Medical/ Clinical functions in the bio-tech industry in Europe and in USA at Shire, Baxalta, Baxter- Haematology, Baxter-Vaccines, Novartis-Vaccines, GSK-Vaccines and UCB.

More news